EAACI Congress 2024 https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spain, March 19, 2024 (GLOBE NEWSWIRE) — The European Academy of Allergy and Clinical Immunology (EAACI), with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements in allergy and clinical immunology. We are thrilled

NEW YORK, N.Y., March 12, 2024 (GLOBE NEWSWIRE) — The Women in the Digital Economy Fund (WiDEF), a five-year $60.5 million investment to accelerate progress on closing the global gender digital divide, announces its first call for applications with recorded remarks from the United States Agency for International Development (USAID)

Quantexa supporting rising wave of organizations using data, analytics, and AI to break down silos Partnership with Microsoft makes Quantexa’s Decision Intelligence Platform immediately available on Microsoft Azure Marketplace; company commits to build solutions natively on Azure Technology preview demonstrates Quantexa’s ambitious plan to accelerate platform, solution and generative

Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure-play contract research organization Creates standalone best-in-class Randomization and Trial Supply Management and Patient Access solutions positioned for differentiation and growth DURHAM, N.C., March 11, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the

Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the heart of King’s Cross neighborhood LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio

Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the heart of King’s Cross neighborhood LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio

Campaign includes the groundbreaking WTA Foundation Global Women’s Health Fund, which aims to help at least 1 million women in its first year with an inaugural donation from WTA Tour title sponsor Hologic St. Petersburg, Fla. and Seattle, March 08, 2024 (GLOBE NEWSWIRE) — Today, on International Women’s Day, the

Zurich, March 07, 2024 (GLOBE NEWSWIRE) — Hitachi Energy today announced that Andreas Schierenbeck will be appointed as the new Chief Executive Officer, effective July 1, 2024. Claudio Facchin, Hitachi Energy CEO, will step down at the end of June 2024. Andreas will engage with the Hitachi Energy Board, Executive